Trials / Unknown
UnknownNCT02448121
Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease
Treatment for Hip, Knee, Ankle and Shoulder Osteonecrosis With Autologous Mononuclear Cells Transplantation in People With Sickle Cell Disease
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Federal University of Bahia · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of autologous bone marrow stem cells in sickle cell disease patients with osteonecrosis
Detailed description
The aim of this study is to evaluate autologous bone marrow stem cells transplantation as a safe and potentially beneficial treatment for sickle cell disease patients with osteonecrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous bone marrow stem cell graft | All patients will undergo autologous bone marrow stem cell implantation into the necrotic lesion area using a minimally invasive technique. |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2018-07-01
- Completion
- 2018-08-01
- First posted
- 2015-05-19
- Last updated
- 2017-11-20
Source: ClinicalTrials.gov record NCT02448121. Inclusion in this directory is not an endorsement.